242 related articles for article (PubMed ID: 19515136)
1. Neutrophils and B lymphocytes in ANCA-associated vasculitis.
Witko-Sarsat V; Daniel S; Noël LH; Mouthon L
APMIS Suppl; 2009 Jun; (127):27-31. PubMed ID: 19515136
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of ANCA-associated systemic vasculitis.
Harper L; Savage CO
J Pathol; 2000 Feb; 190(3):349-59. PubMed ID: 10685069
[TBL] [Abstract][Full Text] [Related]
3. Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti proteinase 3 antibodies.
Brachemi S; Mambole A; Fakhouri F; Mouthon L; Guillevin L; Lesavre P; Halbwachs-Mecarelli L
J Am Soc Nephrol; 2007 Aug; 18(8):2330-9. PubMed ID: 17634439
[TBL] [Abstract][Full Text] [Related]
4. B cell targeted therapies in autoimmune diseases.
Isenberg DA
J Rheumatol Suppl; 2006 May; 77():24-8. PubMed ID: 16652442
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
6. [Vasculitis--aspect of cellular and molecular pathogenesis].
Gröne HJ
Verh Dtsch Ges Pathol; 2001; 85():142-52. PubMed ID: 11894391
[TBL] [Abstract][Full Text] [Related]
7. Activation, apoptosis, and clearance of neutrophils in Wegener's granulomatosis.
van Rossum AP; Limburg PC; Kallenberg CG
Ann N Y Acad Sci; 2005 Jun; 1051():1-11. PubMed ID: 16126939
[TBL] [Abstract][Full Text] [Related]
8. Review article: Pathogenic role of complement activation in anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.
Van Timmeren MM; Chen M; Heeringa P
Nephrology (Carlton); 2009 Feb; 14(1):16-25. PubMed ID: 19335841
[TBL] [Abstract][Full Text] [Related]
9. ANCA-small vessel vasculitides: what have we (not yet) learned from animal models?
van der Veen BS; Heeringa P
APMIS Suppl; 2009 Jun; (127):21-6. PubMed ID: 19515135
[TBL] [Abstract][Full Text] [Related]
10. A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis.
Damoiseaux J; Dähnrich C; Rosemann A; Probst C; Komorowski L; Stegeman CA; Egerer K; Hiepe F; van Paassen P; Stöcker W; Schlumberger W; Tervaert JW
Ann Rheum Dis; 2009 Feb; 68(2):228-33. PubMed ID: 18375539
[TBL] [Abstract][Full Text] [Related]
11. The importance of resolution of inflammation in the pathogenesis of ANCA-associated vasculitis.
Harper L; Williams JM; Savage CO
Biochem Soc Trans; 2004 Jun; 32(Pt3):502-6. PubMed ID: 15157172
[TBL] [Abstract][Full Text] [Related]
12. Review article: The role of CD4(+) T cells in ANCA-associated systemic vasculitis.
Abdulahad WH; Stegeman CA; Kallenberg CG
Nephrology (Carlton); 2009 Feb; 14(1):26-32. PubMed ID: 19143940
[TBL] [Abstract][Full Text] [Related]
13. Evolving concepts in pathogenesis and treatment of ANCA-associated systemic vasculitides.
Kallenberg CG; Zhao MH
Nephrology (Carlton); 2009 Feb; 14(1):1-2. PubMed ID: 19335840
[No Abstract] [Full Text] [Related]
14. Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils.
Hu N; Westra J; Huitema MG; Bijl M; Brouwer E; Stegeman CA; Heeringa P; Limburg PC; Kallenberg CG
Arthritis Rheum; 2009 May; 60(5):1548-57. PubMed ID: 19404956
[TBL] [Abstract][Full Text] [Related]
15. [Antineutrophil cytoplasmic antibodies and associated diseases].
Sghiri R; Meddeb H; Bouguila J; Jarray M; Bahri F; Nouira R; Zellama D; Achour A; Essoussi AS; Harbi A; Ghedira I
Pathol Biol (Paris); 2009 Jul; 57(5):398-402. PubMed ID: 18834675
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies.
Jennette JC; Xiao H; Falk RJ
J Am Soc Nephrol; 2006 May; 17(5):1235-42. PubMed ID: 16624929
[TBL] [Abstract][Full Text] [Related]
17. Targeting B lymphocytes as therapy for ANCA-associated vasculitis.
Golbin JM; Specks U
Rheum Dis Clin North Am; 2007 Nov; 33(4):741-54, v. PubMed ID: 18037114
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil activation in anti-proteinase 3-positive vasculitis--a prospective study.
Wikman A; Lundahl J; Jacobson SH
Scand J Immunol; 2005 Dec; 62(6):539-45. PubMed ID: 16316421
[TBL] [Abstract][Full Text] [Related]
19. T lymphocytes in patients with primary vasculitis: expansion of CD8+ T cells with the propensity to activate polymorphonuclear neutrophils.
Iking-Konert C; Vogl T; Prior B; Wagner C; Sander O; Bleck E; Ostendorf B; Schneider M; Andrassy K; Hänsch GM
Rheumatology (Oxford); 2008 May; 47(5):609-16. PubMed ID: 18346977
[TBL] [Abstract][Full Text] [Related]
20. MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner.
Hoshino A; Nagao T; Nagi-Miura N; Ohno N; Yasuhara M; Yamamoto K; Nakayama T; Suzuki K
J Autoimmun; 2008 Aug; 31(1):79-89. PubMed ID: 18501296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
